R&D

MedImmune and Abpro Spin Out Antibody Firm

US House set to Pass Medical Funding Bill

Linde May Nail Down Iran LNG

SABIC Builds PP Pilot Plant

'Always Solving' - Ashland Launches New Brand

At the Crossroads of Technology and Information

Valeant Selling Salix to Takeda?

Merck and Pfizer in Lung Pact With Debiopharm

Novartis Axes Swiss and Chinese R&D Sites

Cambrex Validates Milan API Pilot Plant

Sibur Upgrades Tomsk Polymer Production

Trends in Chemical & Pharmaceutical Research

Bayer, Monsanto Sidestep Merger Concerns

Linde and Praxair End Merger Talks

Diagnosis: Innovation Insufficiency – Treatment: Combination Therapy

ISPE Recognizes Leaders in Drug Shortage Prevention

Opportunities in Drug Development and Manufacturing

Growth in the global oncology drug market is an important measure of opportunities in drug development and manufacturing, including for contract manufacturers of active pharmaceutical ingredients (APIs) and finished drug products.

LyondellBasell Picks La Porte for new PE Unit

The Winning Formula

Bridging the Innovation Gap

Metabolix Sells Biopolymer Assets to CJ CheilJedang

Croda and Synthomer Eyeing Deals?

Casebia Moves Research to New Massachusetts Facility

Frutarom Enters Irish Market with Redbrook Buy

Philippe Saudan Chief Development Officer at Kuros

Merck and Nanoco Sign Quantum Materials Deal

CIA Member Survey Reveals Positive UK Outlook

Pfizer Buys Gene Therapy Group Bamboo

GSK and Verily Life Sciences in Bioelectronics JV

US-UK Alliance Fights Antibiotic Resistance

Dystar Plans New Innovation Center at Nanjing

EMA to Review Merck KGaA’s MS Tablets MAA

Celgene and Jounce in Cancer Drug Collaboration

Bayer and X-Chem Expand Drug Discovery Pact

EU Clears Amgen’s Kyprolis Cancer Therapy